Editas Medicine Net Income

Editas Medicine (EDIT) currently reports a net income of $-110M as of March 2026. That compares with $-250M in the prior-year period — up 56.6% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Editas Medicine's net income history and peer comparisons.

Editas Medicine's net income increased from $-250M to $-110M — a 56.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Editas Medicine's net income of $-110M is lower than the Healthcare sector average of $17B. That is roughly 100.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Editas Medicine reported $-110M in net income as of March 2026. That compares with $-250M in the prior-year period — up 56.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Editas Medicine, and consider following EDIT for alerts when major investors trade the stock.